Targeting HER2/neu Oncogene Overexpression With Ado-Trastuzumab Emtansine in the Treatment of Metastatic Salivary Gland Neoplasms: A Single-Institution Experience. Academic Article uri icon

Overview

publication date

  • February 15, 2019

Identity

PubMed Central ID

  • PMC6430573

Scopus Document Identifier

  • 85077485299

Digital Object Identifier (DOI)

  • 10.1200/PO.18.00351

PubMed ID

  • 30906914

Additional Document Info

volume

  • 3